2510例新型冠状病毒筛查的实验室数据分析
该研究回顾性分析了2510例COVID-19筛查患者的核酸和血液学数据,发现COVID-19感染率为1.3%,甲型和乙型流感感染率均为3%。32例COVID-19患者中,部分出现淋巴细胞计数及比值下降、嗜酸性粒细胞计数及比值下降、C反应蛋白升高,且与流感患者及阴性患者相比多种血液学指标存在显著差异。
要点
- 甲型和乙型流感感染率高于COVID-19。
- 咽拭子采集可能引起感染时,可检测粪便样本。
- 评估咽拭子和粪便样本可提高核酸检测阳性率。
核心结论
- 甲型和乙型流感感染率高于COVID-19。
- 当咽拭子采集可能引起感染时,可检查粪便样本,评估咽拭子和粪便样本可提高核酸检测阳性率。
- COVID-19可引起部分血液学指标变化。
研究设计与样本
- 回顾性分析2510例患者的COVID-19感染核酸和血液学数据。
主要发现
- COVID-19、甲型和乙型流感感染率分别为1.3%、3%和3%。
- 8例阳性患者的粪便中检测到COVID-19核酸,但泪液样本中未检测到。
- 32例COVID-19患者中,15例(47%)和16例(50%)分别显示淋巴细胞计数和淋巴细胞比值下降。
- 21例(66%)和24例(75%)分别显示嗜酸性粒细胞计数和嗜酸性粒细胞比值下降,18例(56%)显示C反应蛋白升高。
- COVID-19患者与甲型和乙型流感患者之间有10项血液学指标存在显著差异(P < 0.05),与阴性患者之间有18项血液学指标存在显著差异(P < 0.05)。
临床怎么用
- 在咽拭子采集可能引起感染时,可考虑检测粪便样本。
- 联合评估咽拭子和粪便样本可能提高核酸检测阳性率。
- 关注COVID-19患者的淋巴细胞、嗜酸性粒细胞和C反应蛋白等血液学指标变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Novel coronavirus (COVID-19) is highly infectious and requires early detection, isolation, and treatment. We tried to find some useful information by analyzing the covid-19 screening data, so as to provide help for clinical practice. METHOD: We collected nucleic acid and hematology data from 2510 patients for COVID-19 infection for retrospective analysis. RESULT: COVID-19 and influenza A and B infection rates were 1.3%, 3%, and 3%, respectively. COVID-19 nucleic acid was detected in stool but not in tear samples from 8 positive patients. Among the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte count and lymphocyte ratio, 21(66%) and 24(75%) patients showed decreased eosinophil count and eosinophil ratio, and 18 (56%) patients showed increased C-reactive protein. Ten hematological indicators significantly differed in the blood of patients with COVID-19 and those with influenza A and B (P < 0.05). Eighteen hematological indicators significantly differed between patients with COVID-19 and negative patients (P < 0.05). CONCLUSION: The positive rate of influenza A and B infection was higher than that of COVID-19. When pharyngeal swab collection may cause infection, fecal samples can be examined. Evaluation of pharyngeal swab and fecal samples can improve the positive rate of nucleic acid detection. The COVID-19 can cause some hematological indices changes.
引用
- Yun H, Sun Z, Wu J, et al. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients. Clin Chim Acta. 2020. PMID: 32315614. doi:10.1016/j.cca.2020.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。